Ophthalmic spectroscopy has recently opened promising avenues for early, non-invasive diagnosis of pathological brain conditions. Notably, Raman spectroscopy has been explored for the detection of traumatic brain injury, while hyperspectral imaging has shown potential for the assessment of Alzheimer’s disease in humans. Although the eye provides an optimal optical window for such investigations, several challenges limit the clinical adoption of these label-free techniques, such as the intrinsically weak signal, the strict constraints on eye-safe laser power levels, and the complexity of biomolecular spectral signatures arising from ocular anatomy. This thesis focuses on the development and characterization of an experimental system for ophthalmic Raman spectroscopy, designed to acquire Raman spectra from intact eyes while operating close to eye-safe laser power levels. Following an initial validation on reference substrates, the system was deployed to perform a comparative biomolecular characterization of murine eyes from healthy animals and from a model of neurodegenerative disease (Parkinson’s disease). To enable multimodal measurements, the system was also upgraded with fluorescence lifetime recording capabilities and adapted for acquisitions through optical fibers.

Ophthalmic spectroscopy has recently opened promising avenues for early, non-invasive diagnosis of pathological brain conditions. Notably, Raman spectroscopy has been explored for the detection of traumatic brain injury, while hyperspectral imaging has shown potential for the assessment of Alzheimer’s disease in humans. Although the eye provides an optimal optical window for such investigations, several challenges limit the clinical adoption of these label-free techniques, such as the intrinsically weak signal, the strict constraints on eye-safe laser power levels, and the complexity of biomolecular spectral signatures arising from ocular anatomy. This thesis focuses on the development and characterization of an experimental system for ophthalmic Raman spectroscopy, designed to acquire Raman spectra from intact eyes while operating close to eye-safe laser power levels. Following an initial validation on reference substrates, the system was deployed to perform a comparative biomolecular characterization of murine eyes from healthy animals and from a model of neurodegenerative disease (Parkinson’s disease). To enable multimodal measurements, the system was also upgraded with fluorescence lifetime recording capabilities and adapted for acquisitions through optical fibers.

Development and Validation of an Optical System for Label-Free Ophthalmic Raman Spectroscopy

SEDAZZARI, ANNA
2025/2026

Abstract

Ophthalmic spectroscopy has recently opened promising avenues for early, non-invasive diagnosis of pathological brain conditions. Notably, Raman spectroscopy has been explored for the detection of traumatic brain injury, while hyperspectral imaging has shown potential for the assessment of Alzheimer’s disease in humans. Although the eye provides an optimal optical window for such investigations, several challenges limit the clinical adoption of these label-free techniques, such as the intrinsically weak signal, the strict constraints on eye-safe laser power levels, and the complexity of biomolecular spectral signatures arising from ocular anatomy. This thesis focuses on the development and characterization of an experimental system for ophthalmic Raman spectroscopy, designed to acquire Raman spectra from intact eyes while operating close to eye-safe laser power levels. Following an initial validation on reference substrates, the system was deployed to perform a comparative biomolecular characterization of murine eyes from healthy animals and from a model of neurodegenerative disease (Parkinson’s disease). To enable multimodal measurements, the system was also upgraded with fluorescence lifetime recording capabilities and adapted for acquisitions through optical fibers.
2025
Development and Validation of an Optical System for Label-Free Ophthalmic Raman Spectroscopy
Ophthalmic spectroscopy has recently opened promising avenues for early, non-invasive diagnosis of pathological brain conditions. Notably, Raman spectroscopy has been explored for the detection of traumatic brain injury, while hyperspectral imaging has shown potential for the assessment of Alzheimer’s disease in humans. Although the eye provides an optimal optical window for such investigations, several challenges limit the clinical adoption of these label-free techniques, such as the intrinsically weak signal, the strict constraints on eye-safe laser power levels, and the complexity of biomolecular spectral signatures arising from ocular anatomy. This thesis focuses on the development and characterization of an experimental system for ophthalmic Raman spectroscopy, designed to acquire Raman spectra from intact eyes while operating close to eye-safe laser power levels. Following an initial validation on reference substrates, the system was deployed to perform a comparative biomolecular characterization of murine eyes from healthy animals and from a model of neurodegenerative disease (Parkinson’s disease). To enable multimodal measurements, the system was also upgraded with fluorescence lifetime recording capabilities and adapted for acquisitions through optical fibers.
Raman Spectroscopy
Label-Free
Ocular Spectroscopy
Neurophotonics
File in questo prodotto:
File Dimensione Formato  
Sedazzari_Anna.pdf

Accesso riservato

Dimensione 16.31 MB
Formato Adobe PDF
16.31 MB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/114153